核素诊断药
R&D Pipeline
R&D Pipeline
RDiagnostic Radiopharmaceuticals
Program
Target
Indication
Preclinical
IND
Phase I
Phase II
Phase III
NDA
TrialLocation
18F-LNC1001
PSMA
Prostate Cancer
18F-LNC1016
αvß3
Lung Cancer
18F-LNC1005
FAP
Gastric Cancer
18F-LNC1007
FAP、αvß3
ccRCC
68Ga-LNC1007
FAP、αvß3
ccRCC
18F-LNC1017
CCK2R
SCLC/MTC
18F-LNC1019
GRPR
Breast cancer/ Prostate cance
RTherapeutic Radiopharmaceuticals
Program
Target
Indication
Preclinical
IND
Phase I
Phase II
Phase III
NDA
TrialLocation
177Lu-LNC1011
PSMA
Prostate Cancer
225Ac-LNC1011
PSMA
Prostate Cancer
177Lu-LNC1009
FAP、αvß3
Lung cancer/ Ovarian cancer
212Pb-LNC1011M
PSMA
Prostate Cancer
177Lu-LNC1018
CCK2R
SCLC/MTC
177Lu-LNCAb103
GRPR
Breast cancer/ Prostate cancer
Copyright 2022 Yantai Lannacheng Biotechnology Co., Ltd. All Rights Reserved.